ADA Scientific Sessions 2025 Abstract
Impact of Time of Injection Comparing iGlarLixi vs. IDegAsp in Chinese People with Type 2 Diabetes—Exploratory Analysis of the SoliD Study
Trial in peopleInterventions
The paper
Tianjin
ADA Scientific Sessions 2025 Abstract, 13 Jun 2025
Presented at ADA Scientific Sessions 2025, late-breaking 1988-LB